PIK3CA and adenocarcinoma: Much higher frequencies of PIK3CA mutations, however, were found both in adenocarcinoma (37.5%) and in cervical squamous carcinoma (25%) by mass-spectrometry based analyses [28,45], suggesting either that this technique is much more sensitive than Sanger sequencing or that cancer cases from different populations have different rates of PIK3CA mutations.